We haven’t reached mid-year 2019, and the United States has already experienced several severe weather events, including a polar vortex and many hail storms in the Midwest, massive flooding in the Northern Plains, and heavy El Niño rains in California.
Today's advanced driver-assistance systems (ADAS) do more than reduce the risk of injuries during a crash; some features are designed to help avoid accidents altogether.
The Workers' Compensation Board in New York has been busy with two rulemakings that will affect how pharmacy care is delivered and reimbursed in the Empire State.
Mental health has traditionally been considered a pariah in workers’ compensation claims management. The old way of thinking is that when psychological issues enter the picture, claim costs spin out of control and return-to-work delays soar.
How can the workers' compensation industry learn from other industries in the age of automation and technology? In this article, we will explore the shift to home delivery services and how this shift is relevant to the workers' compensation industry and prescription delivery services.
States are looking at patient opioid agreements, warning labels, colored caps and informed consent.
Today, there are two prescription products for use by laypersons. Namely, auto-injector (Evzio®) and intranasal (Narcan® Nasal Spray) naloxone. While they can be administered by someone outside of the healthcare profession, they are only obtainable with a prescription. The Food and Drug Administration (FDA) believes an over the counter (OTC) version may remove barriers for obtaining naloxone, particularly for people who are not under the care of a physician or who may be hesitant to admit to issues with opioid abuse.